Regan Miles named Vice Chairman, Unigen, Inc.
Regan Miles has been named Vice Chairman of Unigen, Inc. effective August 1, 2021. His transition from President & CEO to Vice Chairman is fundamental to the company’s succession planning and positioning for the future and rapid growth of Unigen. Mr. Miles will be succeeded by Dr. Qi Jia, Ph.D., Unigen’s Chief Scientific Officer.
Mr. Miles began his career with Unigen in 2002 as EVP of Sales & Marketing. He has served two terms as Unigen’s President and CEO, from 2006-2008 and 2015 to the present. During his time with Unigen, Mr. Miles has been instrumental in growing the business from a new research and development firm to a profitable patented ingredient supplier. Under his leadership the biotech company has launched 10 proprietary branded ingredients that ultimately brought to fruition the vision and mission of “Bringing the best of nature to humankind.”
Mr. Miles has 30+ years of experience in the natural products industry. He has held top leadership positions with many of the leading companies in the industry including Nature’s Way, Pharmanex, Integrative Therapeutics, Univera and Next Pharmaceuticals. He has demonstrated a strong record of success in achieving growth and profitability at the companies he has been associated with. As Vice Chairman, Mr. Miles will share his industry knowledge, work in collaboration and mentor Unigen’s new executive leadership.
“Unigen is solidly positioned for phenomenal growth in the next few years,” said Mr. Miles. “Our scientists are engaged in worldwide research collaborations and clinical trials relevant to advancing consumer product development. I am excited to be part of developing the executive leadership that will continue to guide Unigen’s vision and be the driving momentum behind its vertical growth.”
Unigen discovers, develops and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The Company discovers its ingredients through its high throughput screening PhytoLogix® approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits. Mechanism of action, safety and efficacy are documented with extensive preclinical in vitro and in vivo testing and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution and marketing of end-products in each of Unigen’s target markets. www.Unigen.net